Literature DB >> 29600609

[Comparison and review on specifications of fermented Cordyceps sinensis products].

Ping Yang1, Xiao-Xia Zhao1, Yong-Wen Zhang1.   

Abstract

There are five kinds of fermented Cordyceps crude drug and their preparations that have been approved as medicine on the market. Since the initial strains of the crude drug were all isolated from natural Cordyceps sinensis, they have similar names, chemical components and even clinical applications. However, because of the different strain species and fermentation processes, there was significant difference in quality. As a result, they should be clearly distinguished in clinical use. Most of the products were researched and developed during the 1980s and 1990s, so there was difference in quality standards for different products, and their quality control levels of some products were not perfect. At present, some of the products are approved as Chinese medicine, others are approved as chemical drugs, with a confusion in products name, management and clinical application. In this paper, the approval numbers, quality standards and clinical applications, and current problems of these products were summarized and compared; some suggestions were put forward, such as standardizing the product name, unifying the management of approval number category, and increasing the specific quality control attributes, in order to provide reference for standard implementation, quality control and drug regulation for fermented Cordyceps crude drugs and their preparations. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  fermented Cordyceps sinensis ; regulation ; review ; specifications

Mesh:

Substances:

Year:  2018        PMID: 29600609     DOI: 10.19540/j.cnki.cjcmm.20171012.001

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

Review 1.  Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review.

Authors:  Wu Liu; Yiwei Gao; Yi Zhou; Fangning Yu; Xinyi Li; Ning Zhang
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

2.  SiBaoChongCao exhibited anti-fatigue activities and ameliorated cancer cachexia in mice.

Authors:  Qiang Shen; Chun-Xiao Miao; Wan-Li Zhang; Yi-Wei Li; Qiao-Qiao Chen; Xiao-Xiang Li; Xuan Liu; Xiong-Wen Zhang
Journal:  RSC Adv       Date:  2019-06-04       Impact factor: 4.036

3.  [Fingerprint establishment and multi-indicator quantitative analysis of fermented Cordyceps powder and products].

Authors:  Wen Cao; Liang Hong; Ming Yang; Shaoping Li; Jing Zhao
Journal:  Se Pu       Date:  2021-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.